Search Results

1 - 10 of 41 items :

  • "prostate cancer" x
Clear All
Influence of gold marker for magnetic resonance imaging during prostate radiotherapy

References [1] Yamaguchi H, Hori M, Suzuki O, et al . Clinical Significance of the Apparent Diffusion Coefficient Ratio in Prostate Cancer Treatment with Intensity-modulated Radiotherapy Anticancer Res. 2016;36(12):6551-6556. [2] Qi WX, Zhang Q, Li P, et al . The predictive role of ADC values in prostate cancer patients treated with carbon-ion radiotherapy: initial clinical experience at Shanghai Proton and Heavy Ion Center (SPHIC). J Cancer Res Clin Oncol. 2016;142(6):1361-1367. [3] Casares-Magaz O, van der Heide UA, Rørvik J, et al . A

Open access
Evaluation of various common prostate IMRT techniques based on estimated tumor control and normal tissue complication probabilities in correlation with patients anatomical parameters derived from the CT scans

References [1] Center MM, Jemal A, Lortet-Tieulent J, et al . International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61(6):1079-1092. [2] Khan FM, Gerbi BJ. Treatment planning in radiation oncology. Wolters Kluwer Health/Lippincott Williams & Wilkins; 2012. [3] Pan HY, Jiang J, Hoffman KE, et al . Comparative toxicities and cost of intensity-modulated radiotherapy, proton radiation, and stereotactic body radiotherapy among younger men with prostate cancer. J Clin Oncol. 2018;36(18):1823-1830. [4

Open access
Stereotactic radiosurgery of prostate cancer – dose distribution for VMAT and CyberKnife techniques

References [1] Chin LS, Regine WF, editors. Principles and Practice of Stereotactic Radiosurgery. Springer; 2008. [2] Hernández TG, Gonzáleza AV, Peidro JP, et al. Radiobiological comparison of two radiotherapy treatment techniques for high-risk prostate cancer. Rep Pract Oncol Radiother. 2013;18(5):265-271. [3] Ślosarek K, Rembielak A, Maciejewski B. Dynamiczna radiochirurgia - nowe możliwości radioterapii stereotaktycznej. Nowotwory J Oncol. 2003;53(5):546-551. [4] Stąpór-Fudzińska M, Grządziel

Open access
Prediction of the cumulated dose for external beam irradiation of prostate cancer patients with 3D-CRT technique

., Morton, G., Loblaw, D. A., Tirona, R., Pang, G., Choo, R., Szumacher, E., Deboer, G., & Pignol, J. P. (2005). Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys ., 62 (2), 418–425. DOI: 10.1016/j.ijrobp.2004.09.051. 6. Adamczyk, M., Piotrowski, T., Adamiak, E., & Malicki, J. (2014). Dosimetric consequences of prostate-based couch shifts on the precision of dose delivery during simultaneous IMRT irradiation of the prostate, seminal

Open access
A Monte Carlo study on the radio-sensitization effect of gold nanoparticles in brachytherapy of prostate by 103Pd seeds

characterization of the first AMIRS 103Pd brachytherapy source. Appl Radiat Isot 2008;66(12):1856-60. [32] Kim YJ, Park JH, Yun IH, Kim YS. A prospective comparison of acute intestinal toxicity following whole pelvic versus small field intensity-modulated radiotherapy for prostate cancer. Onco Targets Ther. 2016;9:1319-25. [33] Xie WZ, Friedland WF, Li WB, et al. Simulation on the molecular radiosensitization effect of gold nanoparticles in cells irradiated by x-rays. Phys Med Biol 2015; 21;60(16):6195-212. [34] Yang CJ, Chithrani DB. Nuclear Targeting of Gold

Open access
Initial experience of using an iron-containing fiducial marker for radiotherapy of prostate cancer: Advantages in the visualization of markers in Computed Tomography and Magnetic Resonance Imaging

;42(5):2638-2647. [4] Tanaka O, Hayashi S, Matsuo M, et al. Comparison of MRI-based and CT/MRI fusion-based postimplant dosimetric analysis of prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2006;66(2):597-602. [5] Tanaka O, Hattori M, Hirose S. Comparison of the MRI sequences in ideal fiducial marker-based radiotherapy for prostate cancer. Radiother Oncol. 2016;119(Supplement1):S858-S859.

Open access
Measurements of doses from photon beam irradiation and scattered neutrons in an anthropomorphic phantom model of prostate cancer: a comparison between 3DCRT, IMRT and tomotherapy

and neck radiotherapy using IMRT and 3D-CRT. Radiol. Oncol ., 46 (4), 328–336. 10. Van den Heuvel, F., Defraene, G., Crijns, W., & Bogaerts, R. (2012). Out-of-field contributions for IMRT and volumetric modulated arc therapy measured using gafchromic films and compared to calculations using a superposition/convolution based treatment planning system. Radiother. Oncol ., 105 (1), 127–132. 11. Skórska, M., & Piotrowski, T. (2013). Optimization of treatment planning parameters used in tomotherapy for prostate cancer patients. Phys. Med ., 29 (3), 273

Open access
EPID – a useful interfraction QC tool

, et al. Transit dosimetry with an electronic portal imaging device (EPID) for 115 prostate cancer patients. Int J Radiat Oncol Biol Phys. 1999;45(5):1297-1303. [5] Kroonwijk M, Pasma KL, Quint S, et al. In vivo dosimetry for prostate cancer patients using an electronic portal imaging device (EPID); demonstration of internal organ motion. Radiother Oncol. 1998;49(2):125-132. [6] Huyskens D, Van Dam J, Dutreix A. Midplane dose determination using in vivo dose measurements in combination with portal imaging. Phys Med Biol. 1994;39(7):1089-1101. [7

Open access
Toward a better prescription method for external radiotherapy

;52(1):224-235. [10] ICRU. Prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy (IMRT). ICRU Report 83. J ICRU. 2010;10(1):1-106. [11] Mrozowska M, Kukołowicz P. Relationships between various indices of doses distribution homogeneity. Rep Pract Oncol Radiother. 2015;20(4):278-283. [12] Miles EF, Nelson JW, Alkaissi AK, et al. Biologically effective dose (BED) correlation after low-dose rate prostate brachytherapy for clinically low-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2010;77(1):139-146. [13] Hartley A, Sanghera P

Open access
Impact of g-Load Shift on Temporal Expression Pattern of Apoptosis-linked Proteins in the Rat Mammary Gland

between cell death and proliferation. Digestive Diseases and Sciences 51, 1063-1069. 10.1007/s10620-006-8010-2 16865572 Werneck-Silva AL Alvares EP Gama P Damiao AO Osaki LH Ogias D Sipahi AM 2006 Intestinal damage in strongyloidiasis: The imbalance between cell death and proliferation Digestive Diseases and Sciences 51 1063 1069 Winter RN, Kramer A, Borkowski A, Kyprianou N (2001) Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Cancer Res 61, 1227-1232. 11221855 Winter RN Kramer A

Open access